CereGate in a series A round backed by 468 capital and re.Mind Capital.

CereGate, a Munich, German-based software developer, announced raising a new equity investment round.

The money was raised from investors led by 468 capital and re.Mind Capital (Apeiron Investment Group), joined by existing shareholders Heal Capital, High-Tech-Gründerfonds (HTGF) and TruVenturo.

CereGate, founded in 2019 by Balint Varkuti, develops software-based solutions for computer-brain interfaces. The software solution augments the programming of such neuromodulation systems for patients enabling completely novel forms of therapy, e.g. specifically suited to combat gait problems in Parkinson’s disease.

Prior to this round, in 2020, Ceregate raised a seed funding round.